Novartis AG (NVS)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 198.95B |
| Enterprise value | 211.34B |
| Trailing P/E | 23.73 |
| Forward P/E | 13.77 |
| PEG ratio (5-yr expected) | 5.30 |
| Price/sales (ttm) | 4.36 |
| Price/book (mrq) | 4.25 |
| Enterprise value/revenue | 4.53 |
| Enterprise value/EBITDA | 11.58 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.47 |
| 52-week change 3 | -5.13% |
| S&P500 52-week change 3 | 25.01% |
| 52-week high 3 | 108.78 |
| 52-week low 3 | 92.19 |
| 50-day moving average 3 | 98.00 |
| 200-day moving average 3 | 99.75 |
Share statistics
| Avg vol (3-month) 3 | 1.58M |
| Avg vol (10-day) 3 | 2.03M |
| Shares outstanding 5 | 2.04B |
| Implied shares outstanding 6 | 2.05B |
| Float 8 | 1.96B |
| % held by insiders 1 | 0.00% |
| % held by institutions 1 | 6.92% |
| Shares short (28 Mar 2024) 4 | 4.21M |
| Short ratio (28 Mar 2024) 4 | 2.77 |
| Short % of float (28 Mar 2024) 4 | N/A |
| Short % of shares outstanding (28 Mar 2024) 4 | 0.21% |
| Shares short (prior month 29 Feb 2024) 4 | 4.53M |
Dividends & splits
| Forward annual dividend rate 4 | 3.78 |
| Forward annual dividend yield 4 | 3.88% |
| Trailing annual dividend rate 3 | 3.92 |
| Trailing annual dividend yield 3 | 4.03% |
| 5-year average dividend yield 4 | 3.58 |
| Payout ratio 4 | 85.33% |
| Dividend date 3 | 19 Apr 2024 |
| Ex-dividend date 4 | 07 Mar 2024 |
| Last split factor 2 | 1116:1000 |
| Last split date 3 | 09 Apr 2019 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 31.94% |
| Operating margin (ttm) | 30.78% |
Management effectiveness
| Return on assets (ttm) | 8.65% |
| Return on equity (ttm) | 19.83% |
Income statement
| Revenue (ttm) | 47.73B |
| Revenue per share (ttm) | 23.17 |
| Quarterly revenue growth (yoy) | 9.70% |
| Gross profit (ttm) | N/A |
| EBITDA | 18.94B |
| Net income avi to common (ttm) | 9.11B |
| Diluted EPS (ttm) | 4.10 |
| Quarterly earnings growth (yoy) | 17.20% |
Balance sheet
| Total cash (mrq) | 9.65B |
| Total cash per share (mrq) | 4.73 |
| Total debt (mrq) | 27.28B |
| Total debt/equity (mrq) | 68.63% |
| Current ratio (mrq) | 0.90 |
| Book value per share (mrq) | 19.44 |
Cash flow statement
| Operating cash flow (ttm) | 13.77B |
| Levered free cash flow (ttm) | 13.33B |
© 2024 Yahoo. All rights reserved.